Financial Performance - Amplify Energy reported a net loss of approximately $21.0 million in Q3 2025, compared to a net income of $6.4 million in the prior quarter, primarily due to a $34.0 million impairment charge[6][18]. - Total revenues excluding hedges for Q3 2025 were approximately $66.4 million, lower than $68.4 million in the previous quarter due to decreased commodity prices[8][13]. - The company reported a net loss of $20.966 million for the quarter, compared to a net income of $6.384 million in the previous quarter[39]. - Free Cash Flow for the three months ended September 30, 2025, was $(684,000), an improvement from $(10,147,000) in the previous quarter[44]. - Total revenues for the three months ended September 30, 2025, were $66.396 million, a decrease from $68.361 million for the previous quarter[39]. Production and Sales - Average daily production increased to 19.7 MBoepd in Q3 2025, up 0.6 MBoepd from the previous quarter, with a 10% increase when adjusting for the Eagle Ford divestiture[5][10]. - Average production volumes for the quarter were 1,811 MBoe, an increase from 1,740 MBoe in the prior quarter[40]. - Total production volumes for the three months ended September 30, 2025, reached 1,811 MBOE, an increase from 1,740 MBOE in the previous quarter, representing a 4.1% growth[41]. - Oil and natural gas sales amounted to $64.242 million for the quarter, down from $66.774 million in the prior quarter[40]. - Average sales price for oil was $60.72 per barrel, slightly up from $60.01 per barrel in the previous quarter[40]. Expenses and Costs - Lease operating expenses decreased to approximately $35.6 million in Q3 2025, down $3.0 million from the prior quarter, with a cost of $19.67 per Boe[15]. - Amplify's lease operating expense for the quarter was $35.613 million, down from $38.622 million in the previous quarter[39]. - Lease operating expenses totaled $35,613,000 for the three months ended September 30, 2025, down from $38,622,000 in the previous quarter, a decrease of 7.8%[41]. - Adjusted EBITDA for Q3 2025 was $20.3 million, a 7% increase from the prior quarter, driven by lower lease operating expenses[7]. Capital Expenditures and Investments - Capital investment in Q3 2025 was approximately $17.5 million, with 89% allocated to development drilling and facility projects at Beta[19][20]. - Total capital expenditures for the three months ended September 30, 2025, amounted to $17,470,000, down from $25,516,000 in the previous quarter, indicating a 31.6% decrease[43]. Asset Management and Divestitures - Amplify has entered into agreements to divest its Oklahoma and East Texas assets for a total consideration of $220.0 million, expected to close in Q4 2025[2][4]. - The company plans to use proceeds from asset divestitures to pay down outstanding debt of $123.0 million and to accelerate development at Beta[3][9]. Impairment and Hedging - The company reported an impairment expense of $34.002 million for the quarter, significantly higher than $8.448 million in the prior quarter[39]. - Amplify executed crude oil swaps covering portions of 2026 and 2027 at a weighted average price of $62.29[26]. - The company has hedged natural gas volumes averaging 560,000 MMBtu per month for 2025 at a weighted average fixed price of $3.75[27]. - Amplify maintains a robust hedge book to support its cash flow profile and provide downside protection in weak commodity price environments[26]. Balance Sheet and Equity - Total assets decreased to $731,355,000 as of September 30, 2025, from $771,307,000 at the end of the previous quarter, a decline of 5.2%[42]. - Total liabilities decreased to $338,381,000 as of September 30, 2025, from $360,002,000 in the previous quarter, a reduction of 6.0%[42]. - Shareholders' equity decreased to $392,974,000 as of September 30, 2025, down from $411,305,000 in the previous quarter, reflecting a 4.4% decline[42]. Future Expectations - Amplify expects to generate annualized lease operating expense savings of approximately $10 million from new CO2 contracts and facility upgrades at Bairoil[5][24].

Financial Performance - For the three months ended September 30, 2025, the return on average total assets was 1.27%, compared to 0.48% for the same period in 2024[200]. - The Company reported a diluted earnings per common share of $0.65 for the three months ended September 30, 2025, compared to $0.26 for the same period in 2024[200]. - Net income for the three months ended September 30, 2025, was $16,924 thousand, down from $20,252 thousand in the same period in 2024, a decrease of 16.3%[202]. - Net income for Q3 2025 was $16.9 million, a 225.0% increase from $5.2 million in Q3 2024, resulting in $0.65 per diluted share[209]. - For the nine months ended September 30, 2025, net income reached $50.5 million, up 182.9% from $17.8 million in the same period of 2024, translating to $1.95 per diluted share[210]. Revenue and Income Sources - Noninterest income as a percentage of revenue was 40.56% for the three months ended September 30, 2025, down from 55.72% in the same period of 2024[200]. - Noninterest income for the nine months ended September 30, 2025, was $88,824 thousand, up from $81,057 thousand in the same period of 2024, indicating a rise of 9.5%[202]. - Total noninterest income for the three months ended September 30, 2025 was $29.4 million, an increase of $1.1 million, or 3.8%, from the same period in 2024[225]. - Mortgage banking revenue for the three months ended September 30, 2025 increased by $0.9 million, or 35.0%, compared to the same period in 2024[225]. Asset and Loan Growth - Total assets reached $5,330,573 thousand as of September 30, 2025, compared to $4,084,640 thousand a year prior, marking a growth of 30.5%[202]. - Loans increased to $4,102,075 thousand as of September 30, 2025, up from $3,032,343 thousand a year earlier, representing a growth of 35.4%[202]. - Total loans for the nine months ended September 30, 2025 amounted to $52.1 million, an increase of $14.5 million, or 38.5%, compared to the same period in 2024[222]. - Total loans outstanding reached $4.1 billion as of September 30, 2025, an increase of $109.5 million, or 2.7%, from December 31, 2024[248]. Equity and Capital - Total stockholders' equity increased to $550,688 thousand as of September 30, 2025, from $386,486 thousand a year earlier, a growth of 42.4%[202]. - Tangible common equity to tangible assets ratio improved to 8.24% as of September 30, 2025, compared to 7.13% a year earlier[204]. - Stockholders' equity increased by $55.3 million, or 11.2%, to $550.7 million as of September 30, 2025[284]. - Common equity tier 1 capital to risk-weighted assets increased to 10.84% as of September 30, 2025, from 9.91% as of December 31, 2024[288]. Interest Income and Margin - Net interest income for the three months ended September 30, 2025, was $43,136 thousand, compared to $22,542 thousand for the same period in 2024, reflecting an increase of 91.2%[202]. - The net interest margin (taxable-equivalent basis) for the three months ended September 30, 2025, was 3.50%, compared to 2.23% for the same period in 2024[200]. - Total interest income for the three months ended September 30, 2025 was $11.9 million, an increase of $6.9 million, or 138.5%, compared to the same period in 2024[222]. - The net interest margin for Q3 2025 was 3.50%, compared to 2.23% in Q3 2024, driven by higher rates on interest-earning assets and lower rates paid on deposits[216]. Expenses and Efficiency - The efficiency ratio for the three months ended September 30, 2025, was 65.34%, compared to 80.29% for the same period in 2024[200]. - Total noninterest expense for the three months ended September 30, 2025 was $50.5 million, an increase of $8.1 million, or 19.1%, compared to $42.4 million for the same period in 2024[228]. - The company experienced a $29.1 million increase in noninterest expenses for the nine months ended September 30, 2025, impacting overall earnings[211]. - Adjusted efficiency ratio improved to 65.22% for the three months ended September 30, 2025, from 62.35% in the previous quarter[207]. Credit Quality and Risk Management - The provision for credit losses was $1,661 thousand for the three months ended September 30, 2025, compared to $863 thousand for the same period in 2024, reflecting an increase of 92.5%[202]. - Nonperforming loans increased from $62,886 thousand as of December 31, 2024 to $59,644 thousand as of September 30, 2025, with nonperforming loans to total loans ratio at 1.45%[265]. - The allowance for credit losses (ACL) on loans increased from $39,142 thousand as of September 30, 2024 to $62,127 thousand as of September 30, 2025, reflecting a rise of approximately 58.7%[269]. - The company employs a centralized credit risk management strategy, focusing on diversification across geographic, industry, and client levels[262]. Liquidity and Funding - Total deposits increased to $4.4 billion as of September 30, 2025, up $34.2 million, or 0.8%, from December 31, 2024[275]. - On-balance sheet liquidity was $566.9 million as of September 30, 2025, compared to $579.0 million as of December 31, 2024[292]. - Off-balance sheet liquidity decreased to $2.2 billion as of September 30, 2025, down from $2.3 billion as of December 31, 2024[293]. - The Company can accept wholesale deposits up to 20.0% of total assets, equating to $1.1 billion, as of September 30, 2025[295]. Operational and Strategic Risk - Operational risk management focuses on strengthening internal controls and enterprise risk management to mitigate potential losses[309]. - Compliance risk includes potential regulatory sanctions and reputational impacts related to various banking regulations[310]. - Strategic risk is mitigated through initiatives aimed at understanding and reporting on various risks, including new product development[311].

Customer Growth and Engagement - As of September 30, 2025, Klaviyo had over 183,000 customers, with a year-over-year growth of 36% in customers generating over $50,000 of ARR, increasing from 2,619 to 3,563 customers[118] - Klaviyo's land-and-expand strategy aligns revenue growth with customer success, as increased usage of the platform leads to higher subscription tiers and additional service adoption[105] - Klaviyo's KAV (Klaviyo Attributed Value) serves as a measure of the revenue generated for customers through its platform, illustrating the value provided to clients[121] Revenue Performance - Revenue for the three months ended September 30, 2025 increased by $75.8 million or 32.2%, reaching $310.9 million compared to $235.1 million for the same period in 2024[144] - Revenue for the nine months ended September 30, 2025 increased by $216.5 million or 32.4%, totaling $883.8 million compared to $667.3 million for the same period in 2024[145] - Sales to existing customers accounted for approximately 44% of the revenue increase for the three months ended September 30, 2025, while new customers contributed approximately 56%[144] - Sales to existing customers accounted for approximately 42% of the revenue increase for the nine months ended September 30, 2025, with new customers contributing approximately 58%[145] International Expansion - International sales accounted for 34.6% of total revenue for the nine months ended September 30, 2025, indicating significant growth in global markets[110] - The company has expanded its operations internationally, with new offices in Singapore and France in 2025, further enhancing its market presence[110] Product Development and Innovation - Klaviyo's platform has expanded its product offerings, including the introduction of Klaviyo B2C CRM and AI-powered solutions, enhancing customer engagement capabilities[101] - Klaviyo's investment in innovation has led to the development of advanced features in its platform, including AI capabilities for data segmentation and campaign orchestration[111] - The company aims to penetrate new industry verticals, such as education and travel, indicating a strategy for diversification beyond retail and eCommerce[114] Financial Performance and Expenses - The cost of revenue for the three months ended September 30, 2025 was $76.1 million, representing 24.5% of revenue, compared to 23.1% for the same period in 2024[143] - Gross profit for the three months ended September 30, 2025 was $234.7 million, which is 75.5% of revenue, down from 76.9% in the same period of 2024[143] - Selling and marketing expenses for the three months ended September 30, 2025 were $127.7 million, accounting for 41.1% of revenue, compared to 42.5% in the same period of 2024[143] - Research and development expenses for the three months ended September 30, 2025 were $72.7 million, representing 23.4% of revenue, slightly down from 23.7% in the same period of 2024[143] - General and administrative expenses for the three months ended September 30, 2025 were $45.3 million, which is 14.6% of revenue, down from 16.3% in the same period of 2024[143] Cash Flow and Liquidity - As of September 30, 2025, the company's principal sources of liquidity included cash, cash equivalents, and restricted cash totaling $981.0 million[164] - As of September 30, 2025, the company's total working capital increased to $882.5 million from $779.9 million as of December 31, 2024, representing a growth of approximately 13.2%[167] - Net cash provided by operating activities for the nine months ended September 30, 2025, was $124.8 million, an increase from $105.9 million for the same period in 2024, reflecting a growth of approximately 17.8%[171][173] - Cash, cash equivalents, and restricted cash at the end of the period increased to $981.0 million as of September 30, 2025, up from $827.9 million at the end of September 30, 2024, marking an increase of approximately 18.5%[171] - The company expects continued growth in cash balances as business operations expand, indicating a positive outlook for liquidity management[178] Investment Activities - Net cash used in investing activities for the nine months ended September 30, 2025, was $24.8 million, compared to $11.6 million for the same period in 2024, indicating a significant increase in investment activities[174][176] Debt and Obligations - The company had no debt as of September 30, 2025, which eliminates potential market risk for interest expense[184] - Noncancellable lease obligations as of September 30, 2025, totaled $142.3 million, with $25.3 million payable within the next 12 months[179] Currency and Risk Management - The company has not entered into any hedging arrangements for foreign currency risk, although it may consider doing so in the future[187]

Revenue Performance - Revenue for the three months ended September 30, 2025, was $224.166 million, a 20.7% increase from $185.621 million in the same period of 2024[71]. - The company recognized $186.2 million of revenue from deferred revenue during the three months ended September 30, 2025[72]. - Subscription and support revenue from the Americas for the three months ended September 30, 2025, was $164,847,000, compared to $138,833,000 in 2024, indicating a growth of about 18.7%[81]. - Approximately 91% of total Americas revenue attributed to the U.S. during the three months ended September 30, 2025[81]. Financial Position - As of September 30, 2025, total accrued expenses and other current liabilities amounted to $120.159 million, compared to $126.508 million as of December 31, 2024, reflecting a decrease of approximately 5.3%[42]. - Cash equivalents and marketable securities totaled $732.987 million as of September 30, 2025, with $192.110 million included in cash and cash equivalents and $540.877 million in marketable securities[43]. - The fair value of convertible senior notes due in 2026 and 2028 was $85.1 million and $689.4 million, respectively, as of September 30, 2025[52]. - As of September 30, 2025, the total net carrying amount of intangible assets was $23,533,000, an increase from $27,389,000 as of December 31, 2024[74]. - The balance of goodwill increased from $196,844,000 at December 31, 2024, to $205,955,000 as of September 30, 2025, reflecting a foreign currency translation adjustment of $9,111,000[76]. Expenses and Losses - Stock-based compensation expense for the three months ended September 30, 2025, totaled $30.246 million, compared to $27.470 million for the same period in 2024[66]. - The net loss for the nine months ended September 30, 2025, was $(35,419,000), compared to a net loss of $(43,008,000) for the same period in 2024[78]. - The diluted net income per share for the three months ended September 30, 2025, was $0.05 for both Class A and Class B shares, compared to a loss of $(0.31) per share in 2024[78]. Accounting and Regulatory Impact - The enactment of the One Big Beautiful Bill Act of 2025 had an immaterial favorable impact on the company's income tax expense and tax receivable[38]. - The company anticipates no material impact on its financial statements from the new accounting standards issued by the FASB, effective after December 15, 2024, and December 15, 2026[39][40]. - The company is assessing the impact of new accounting pronouncements on its consolidated financial statements and related disclosures[40]. Cash Flow and Financing Activities - The company’s operating cash flow may be affected by the timing of employee cash bonus payments and commission payouts, particularly in the first and fourth quarters[33]. - The company issued $345.0 million of 1.125% convertible senior notes due 2026, with proceeds totaling $335.9 million after discounts and costs[53]. - In August 2023, the company issued $702.0 million of 1.250% convertible senior notes due 2028, with proceeds totaling $691.1 million after discounts and costs[54]. - For the three months ended September 30, 2025, total interest expense related to the Notes was $3.005 million, compared to $3.003 million for the same period in 2024[63]. Employee Compensation - Accrued bonuses increased significantly from $7.891 million as of December 31, 2024, to $26.834 million as of September 30, 2025[42]. - During the nine months ended September 30, 2025, 227,124 shares were purchased under the Employee Stock Purchase Plan (ESPP), generating cash proceeds of $13.7 million[69]. Amortization and Intangible Assets - Amortization expense for intangible assets was $1.7 million for the three months ended September 30, 2025, compared to $2.0 million for the same period in 2024[75]. - The expected total amortization expense for intangible assets is projected to be $23,533,000 over the remaining fiscal years[76].

Financial Performance - Net sales for the first nine months of 2025 were $4.5 billion, an increase of $444.3 million or 11.0% compared to the same period in 2024, primarily driven by TAVR and TMTT product sales [145]. - Gross profit increased in the nine months ended September 30, 2025, but as a percentage of sales decreased due to foreign currency fluctuations and higher operational expenses [146]. - Net sales in the United States for the three months ended September 30, 2025, were $907.5 million, a 12.8% increase from $804.6 million in 2024 [150]. - TAVR product sales for the three months ended September 30, 2025, were $1,149.9 million, a 12.4% increase from $1,023.3 million in 2024 [151]. - TMTT product sales increased by 59.3% for the three months ended September 30, 2025, reaching $145.2 million compared to $91.1 million in 2024 [151]. Expenses - SG&A expenses increased due to higher personnel-related costs and performance-based compensation, with foreign currency fluctuations adding $7.3 million to expenses for the three months ended September 30, 2025 [172]. - R&D expenses increased due to heightened clinical activity related to heart failure management innovations [175]. Taxation - The effective income tax rate for the nine months ended September 30, 2025, was 16.1%, up from 9.2% in 2024, primarily due to global minimum tax increases and reduced tax benefits from employee share-based compensation [183]. - The company expects an additional tax expense of approximately $50 million in 2025 due to the implementation of the OECD's Pillar Two rules, which impose a global minimum tax of 15% on reported profits [184]. - The IRS proposed a substantial increase to the company's taxable income for the 2015 through 2017 tax years, potentially resulting in an additional tax expense of approximately $255 million [188]. - The company plans to contest the IRS's claim for an additional tax of $269.3 million for the 2015 through 2017 tax years through the judicial process [189]. Cash and Investments - As of September 30, 2025, the company had cash and cash equivalents of $3.4 billion in the United States and $438.0 million outside the United States [196]. - The company had $1,223.2 million in investments in debt securities and $207.9 million in investments in equity instruments as of September 30, 2025, exposing it to investment risks [211]. Shareholder Actions - The company repurchased 11.2 million shares at an aggregate cost of $844.9 million during the nine months ended September 30, 2025, with remaining authority to purchase $2.1 billion of common stock [199]. Acquisitions and Divestitures - The company entered into a definitive agreement to sell a non-core product group for $85 million, with additional earnouts of up to $40 million expected to close in Q4 2025 [141]. - The company entered into agreements to acquire multiple medical device companies for a total cash purchase price of $1.5 billion, with three transactions closed in 2024 for $1.1 billion [200]. Cash Flow - Net cash flows provided by operating activities increased by $474.5 million to $1,144.3 million for the nine months ended September 30, 2025, primarily due to lower tax payments and improved operating performance [204]. - Net cash used in investing activities was $514.6 million for the nine months ended September 30, 2025, primarily due to net purchases of investments and capital expenditures [205]. - Net cash used in financing activities was $945.4 million for the nine months ended September 30, 2025, primarily due to purchases of treasury stock [207]. Regulatory Approvals - The company received FDA approval for the SAPIEN 3 platform for severe aortic stenosis patients without symptoms in April 2025 [155].

For more information, please visit www.generationbio.com. Exhibit 99.1 Generation Bio Announces Third Quarter 2025 Financial Results CAMBRIDGE, MASS., November 5, 2025 -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company, today reported third quarter financial results. Third Quarter 2025 Financial Results About Generation Bio Generation Bio is a biotechnology company that was historically working to change what's possible for people living with T cell-driven autoimmune diseases. In August 2025, the ...

Exhibit 99.1 Snap Inc. Announces Third Quarter 2025 Financial Results Third quarter revenue increased 10% year-over-year to $1,507 million Daily Active Users increased 8% year-over-year to 477 million Monthly Active Users increased 7% year-over-year to 943 million Operating cash flow was $146 million and Free Cash Flow was $93 million SANTA MONICA, Calif. – November 5, 2025 – Snap Inc. (NYSE: SNAP) today announced financial results for the quarter ended September 30, 2025. "Our focus on performance, creativ ...

Revenue Growth - Total Revenue increased 4% year over year to $1.12 billion, with 70% derived from recurring revenue streams[6] - ATM hardware revenue grew 24% year over year, contributing to the expansion of the global installed base[1] - ATM as a Service (ATMaaS) revenue grew nearly 40% year over year, with expectations of over 40% growth in Q4[6] - Core Revenue, excluding Voyix, improved 6% to $1.11 billion, driven by growth in ATMaaS and hardware demand[5] - Total revenue for Q3 2025 was $1,121 million, a 4.5% increase from $1,073 million in Q3 2024[22] - Product revenue increased to $274 million in Q3 2025, up 17.1% from $234 million in Q3 2024[22] - Service revenue remained stable at $847 million in Q3 2025 compared to $839 million in Q3 2024[22] - Annualized Recurring Revenue (ARR) for Q3 2025 reached $1,712 million, up from $1,645 million in Q3 2024, indicating a growth of 4.1%[39] - Recurring revenue accounted for 70% of total revenue in Q3 2025, compared to 73% in Q3 2024[39] - Total revenue for Q3 2025 was $1,121 million, a 4.5% increase from $1,073 million in Q3 2024[39] Profitability Metrics - Net Income attributable to Atleos rose 24% to $26 million, maintaining a net income margin of 2%[8] - Adjusted EBITDA increased 7% to $219 million, with an adjusted EBITDA margin of 19.5%[9] - Gross Profit for Q3 2025 increased 6% to $271 million, with a Gross Margin of 24.2%[7] - Gross profit for Q3 2025 was $271 million, representing a gross margin of 24.2%, up from 23.9% in Q3 2024[22] - Adjusted Diluted Earnings per Share increased 22% to $1.09, compared to $0.89 in the prior year period[6] - Basic net income per share attributable to Atleos common stockholders was $0.35 for Q3 2025, up from $0.29 in Q3 2024[22] - Diluted earnings per share (Non-GAAP) for Q3 2025 was $1.09, compared to $0.89 in Q3 2024, reflecting a growth of 22.5%[41] Cash Flow and Liquidity - Net Cash Flow from operating activities was $27 million, with Adjusted Free Cash Flow at $124 million[10] - Net cash provided by operating activities for the nine months ended September 30, 2025, was $125 million, compared to $264 million for the same period in 2024[26] - Cash and cash equivalents at the end of Q3 2025 were $587 million, down from $684 million at the end of Q3 2024[26] - Net cash provided by operating activities in Q3 2025 was $27 million, down from $107 million in Q3 2024[43] - Adjusted free cash flow-unrestricted for Q3 2025 was $124 million, significantly higher than $38 million in Q3 2024[43] Assets and Liabilities - Total assets as of September 30, 2025, were $5,650 million, an increase from $5,535 million as of December 31, 2024[24] - Total liabilities as of September 30, 2025, were $5,319 million, slightly up from $5,312 million as of December 31, 2024[24]

Revenue Performance - Revenue for Q3 2025 was $241.0 million, an increase of $58.8 million (32.2%) compared to Q3 2024, driven by strong recovery in Jasper properties and new experiences[3] - Total revenue for the three months ended September 30, 2025, was $241,022,000, representing a 32.2% increase from $182,257,000 in the same period of 2024[28] - Revenue growth excluding Jasper properties and new experiences was $17.7 million (12%), driven by yield optimization and increased visitation[9] - Revenue from ticket, rooms, transportation, and other services increased by 34.0% to $178,140,000, while food and beverage and retail products revenue rose by 27.6% to $62,882,000[28] Net Income and Earnings - Net income attributable to Pursuit for Q3 2025 was $73.9 million, up from $48.6 million in the prior year, reflecting a 51.9% increase[3] - Net income for the three months ended September 30, 2025, was $85,101,000, a 52.3% increase compared to $55,864,000 in the prior year[28] - Net income attributable to Pursuit for the three months ended September 30, 2025, was $73,853,000, representing a $25,238,000 increase or 51.9% compared to $48,615,000 in 2024[37] - Adjusted net income for the three months ended September 30, 2025, was $75,316,000, an increase of $24,616,000 or 48.6% from $50,700,000 in 2024[42] - Basic income per common share for the three months ended September 30, 2025, was $2.61, a 55.4% increase from $1.68 in the prior year[28] Adjusted EBITDA - Adjusted EBITDA for Q3 2025 was $117.4 million, representing a year-over-year increase of $34.4 million (41.5%)[3] - Adjusted EBITDA for the three months ended September 30, 2025, was $117,355,000, reflecting a 41.5% increase from $82,931,000 in the same period of 2024[48] - Full year 2025 adjusted EBITDA guidance raised to a range of $116 million to $122 million, an increase of $6 million at the midpoint compared to previous guidance[14] - Adjusted EBITDA margin improved to 48.7% for Q3 2025, up from 45.5% in Q3 2024, indicating enhanced operational efficiency[48] Financial Health and Liquidity - Pursuit's total liquidity was $274.4 million as of September 30, 2025, including $33.8 million in cash and $240.6 million available on its revolving credit facility[9] - The net leverage ratio was 0.7x at the end of Q3 2025, significantly below the target range of 2.5x to 3.5x, indicating strong financial health[9] Expenses and Costs - Operating expenses for the three months ended September 30, 2025, increased by 26.3% to $86,592,000, primarily due to higher variable costs associated with increased transaction volumes[30] - Selling, general, and administrative expenses rose by 20.0% to $17,445,000, driven by transaction-related costs and higher variable compensation accruals[31] - Interest expense decreased by 18.1% to $2,835,000 in Q3 2025 from $3,461,000 in Q3 2024[48] - Income tax expense increased by 69.1% to $17,771,000 in Q3 2025 compared to $10,507,000 in Q3 2024[48] Strategic Initiatives and Growth - The company has identified over $250 million in organic growth investments planned from 2025 to 2030 to fuel long-term growth[11] - Pursuit completed the $111 million acquisition of Tabacón Thermal Resort & Spa in July 2025, enhancing its portfolio in Costa Rica[13] - Pursuit's Refresh, Build, Buy strategy continues to drive growth, with a robust pipeline of acquisition opportunities and organic investments[10] - The company anticipates continued growth in the travel industry and plans to focus on capital expenditures and acquisitions to support its growth strategies[27] - The company is developing a new Flyover attraction in Chicago, which is part of its market expansion strategy[49] Other Financial Metrics - Income from continuing operations before income taxes increased by 73.2% to $105,754,000, up from $61,048,000 in the same quarter of 2024[28] - Income from continuing operations attributable to Pursuit for the three months ended September 30, 2025, was $76,735,000, a significant increase of $33,443,000 or 77.2% from $43,292,000 in 2024[42] - The effective tax rate for the three months ended September 30, 2025, was 16.8%, down from 17.2% in the same period of 2024[34] - The company recorded a gain of $4.2 million for business interruption proceeds related to the Jasper wildfires during the three months ended September 30, 2025[33] - The company reported a $4.2 million gain from business interruption insurance proceeds in Q3 2025 related to lost profits from the Jasper wildfire in 2024[45] - Restructuring charges for the three months ended September 30, 2025, amounted to $424,000, indicating a new expense category for the company[42] - The company experienced a $6,110,000 impairment charge in 2024, which was not present in 2025, reflecting improved asset management[42] - Transaction-related costs and other non-recurring items for the three months ended September 30, 2025, were $(82,000), a decrease of $1,975,000 compared to $1,893,000 in 2024[42] - Net income attributable to non-redeemable noncontrolling interest increased by 56.7% to $11,248,000 in Q3 2025 from $7,178,000 in Q3 2024[48] - Transaction-related costs increased by 68.0% to $1,102,000 in Q3 2025, reflecting ongoing corporate development activities[48]

Financial Performance - Q1 FY2026 revenue reached $171.5 million (ZAR 3.0 billion), representing a 10% increase in ZAR year-on-year[8] - Net revenue for Q1 FY2026 was $86.6 million (ZAR 1.5 billion), up 45% in ZAR compared to Q1 FY2025[8] - Group Adjusted EBITDA for Q1 FY2026 was $15.3 million (ZAR 270.6 million), an increase of 61% in ZAR, meeting the guidance provided[8] - Adjusted earnings for Q1 FY2026 were $5.0 million (ZAR 87.3 million), reflecting a 150% increase in ZAR year-on-year[8] - The company's revenue for the three months ended September 30, 2025, was $171,448,000, an increase of 11.9% from $153,568,000 in the same period of 2024[23] - Group Adjusted EBITDA for the three months ended September 30, 2025, was $15,341,000, up from $9,363,000 in the same period of 2024, indicating a year-over-year increase of 63.5%[22] - The net revenue (non-GAAP) for the three months ended September 30, 2025, was $86,606,000, compared to $58,809,000 in the same period of 2024, reflecting a growth of 47.3%[23] Segment Performance - Merchant Segment revenue was $127.0 million (ZAR 2.2 billion), with net revenue of $44.4 million (ZAR 782.8 million), up 43% in ZAR[8] - Consumer Segment revenue increased to $30.6 million (ZAR 539.0 million), also up 43% in ZAR[8] - Enterprise Segment net revenue was $12.6 million (ZAR 221.6 million), marking a 19% increase in ZAR[8] Future Guidance - For Q2 FY2026, net revenue is expected to be between ZAR 1.575 billion and ZAR 1.725 billion[8] - Full FY2026 guidance includes net revenue between ZAR 6.4 billion and ZAR 6.9 billion, with Group Adjusted EBITDA between ZAR 1.25 billion and ZAR 1.45 billion[8] - Adjusted earnings per share for FY2026 is projected to be at least ZAR 4.60, indicating a year-on-year growth of greater than 100%[8] Loss and Expenses - Lesaka Technologies reported a GAAP net loss of $4,297,000 for the three months ended September 30, 2025, compared to a loss of $4,542,000 in the same period of 2024, representing a decrease of 5.4%[22] - The loss attributable to Lesaka for the year ended June 30, 2025, was $87,634,000, significantly higher than the loss of $17,440,000 for the year ended June 30, 2024[23] - The company reported a basic loss per share of $0.05 for the three months ended September 30, 2025, compared to a loss of $0.07 in the same period of 2024[24] - Lesaka's interest expense for the three months ended September 30, 2025, was $4,898,000, slightly down from $5,032,000 in the same period of 2024[26] - Headline loss per share for the three months ended September 30, 2025, was $0.05, unchanged from the previous year[34] Cash Flow and Assets - Cash flows from operating activities generated $8,923 in the latest quarter, a significant turnaround from a cash outflow of $4,137 in the prior year[28] - Total current assets decreased slightly to $240,544 as of September 30, 2025, from $243,923 as of June 30, 2025[30] - Finance loans receivable increased to $80,860, up from $74,110 in the previous quarter, indicating a 9.8% growth[30] - Inventory levels decreased to $18,957, down from $23,551 in the previous quarter, reflecting a 19.5% reduction[30] - Total liabilities decreased to $386,633 as of September 30, 2025, from $392,327 as of June 30, 2025, showing a 1.0% decline[30] - Cash, cash equivalents, and restricted cash at the end of the period totaled $72,284, down from $76,639 at the beginning of the period[28] Fair Value Adjustments - The company recognized a net gain of $59,828,000 on the change in fair value of equity securities for the year ended June 30, 2025[23] - The company reported a fair value adjustment related to financial liabilities of $(1) for the latest quarter, compared to a positive adjustment of $190 in the prior year[28] Share Information - The weighted average number of shares used to calculate net loss per share increased to 81,327, compared to 64,293 in the prior year, reflecting a 26.6% increase[34]